Search research articles
Contact Us
Filters
Showing results (291-300 of 325) with videos related to
Page
of 33
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
March 17, 2023
S2k-Leitlinie - Merkelzellkarzinom - Update 2022
Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
Max Schlaak, Carolina Cimminiello, Jacopo Pigozzo, et al.
ACS Nano
|
February 1, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
British Journal of Cancer
|
February 14, 2018
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
Markus Hecht, Friedegund Meier, Lisa Zimmer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 10, 2018
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 12, 2017
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Cancers
|
June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
Henner Stege, Maximilian Haist, Michael Schultheis, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 28, 2017
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 2, 2017
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 21, 2022
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 325) with videos related to
Sort By:
Page
of 33
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
March 17, 2023
S2k-Leitlinie - Merkelzellkarzinom - Update 2022
Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
Max Schlaak, Carolina Cimminiello, Jacopo Pigozzo, et al.
ACS Nano
|
February 1, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
British Journal of Cancer
|
February 14, 2018
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
Markus Hecht, Friedegund Meier, Lisa Zimmer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 10, 2018
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 12, 2017
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Cancers
|
June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
Henner Stege, Maximilian Haist, Michael Schultheis, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 28, 2017
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 2, 2017
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 21, 2022
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Page
of 33